Mining The Deep Tech Seam Of Innovation For Healthtech Gold

Encouraging Scientific Advancement Is The Aim Of Singapore’s Multi Stakeholder Investment Organization

Singapore-based SGInnovate has a unique multi stakeholder business model focused on identifying and funding Deep Tech start-ups. CEO Jui Lim now plans to increase the group’s activity in advanced manufacturing and “wetware”  ̶   drugs and diagnostics – as firms increasingly are able to revert to pre-COVID business plans.

Blue Planet Studio

A steady stream of COVID-19 cases in Singapore has been seen in recent months, but unlike in many other advanced economies, incidence has decreased dramatically: since January, community cases have ranged from zero to four daily, and infection cases in travellers have averaged in the low teens ̶ all of which being detected at testing on arrival and during quarantine.

For a highly urbanized parliamentary democracy of 5.5 million people and a population density of 8,136 per square kilometre (third...

More from Global Vision

More from In Vivo

EU Medtech Outlook: The View From MedTech Europe Experts

 
• By 

MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.

‘Confident In Lorundrostat’s Promise’: Mineralys CEO Talks Trials And Next Steps

 

In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.

BioBytes: Qubit Pharmaceuticals Unveils Quantum AI Model For Drug Discovery

 
• By 

Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.